Real-time enrollment status for this follicular lymphoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06911502 |
| Recruiting Status | Recruiting |
| Condition | Follicular Lymphoma |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Celgene |
| Last Updated on CT.gov | May 20, 2026 (May 20, 2026) |
As of October 15, 2026: Clinical trial NCT06911502 is currently recruiting participants. This phase3 study for follicular lymphoma is actively seeking new participants at 31 locations across the United States. The study is sponsored by Celgene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06911502 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06911502 was last updated May 20, 2026 (May 20, 2026). HelloStudys verifies this status automatically.